SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
Quidel plans initial release to professional and point-of-care segments with a goal of expansion to serve telemedicine and home markets Sofia Q is the latest product in Quidel’s best-selling Sofia ...
Doug Bryan, Quidel CEO, joins Yahoo Finance’s Anjalee Khemlani, Alexis Christoforous, and Kristin Myers to discuss the company’s outlook. KRISTIN MYERS: Welcome back. Quidel was given an emergency use ...
The Food and Drug Administration has authorized emergency use of the first antigen coronavirus test, which produces results within minutes and is relatively cheap to make, according to the agency. The ...
The FDA’s emergency use authorization (EUA) program for rapid antigen tests for the COVID-19 pandemic is coming to an end, but few rapid antigen test makers have laid out clear plans regarding the ...
U.S. regulators have approved a new type of coronavirus test that administration officials have touted as a key to opening up the country. The Food and Drug Administration on Saturday announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results